Your browser doesn't support javascript.
loading
Deciphering the chronology of copy number alterations in Multiple Myeloma.
Aktas Samur, Anil; Minvielle, Stephane; Shammas, Masood; Fulciniti, Mariateresa; Magrangeas, Florence; Richardson, Paul G; Moreau, Philippe; Attal, Michel; Anderson, Kenneth C; Parmigiani, Giovanni; Avet-Loiseau, Hervé; Munshi, Nikhil C; Samur, Mehmet Kemal.
Affiliation
  • Aktas Samur A; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA, 02215, USA.
  • Minvielle S; Department of Biostatistics, Harvard T.H. Chan School of Public Health Boston, Boston, MA, 02115, USA.
  • Shammas M; Inserm UMR892, CNRS 6299, Université de Nantes; Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France.
  • Fulciniti M; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Magrangeas F; VA Boston Healthcare System, Boston, MA, 02115, USA.
  • Richardson PG; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Moreau P; Inserm UMR892, CNRS 6299, Université de Nantes; Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France.
  • Attal M; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Anderson KC; Inserm UMR892, CNRS 6299, Université de Nantes; Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France.
  • Parmigiani G; University Cancer Center of Toulouse Institut National de la Santé, Toulouse, France.
  • Avet-Loiseau H; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Munshi NC; Department of Data Sciences, Dana Farber Cancer Institute, Boston, MA, 02215, USA.
  • Samur MK; Department of Biostatistics, Harvard T.H. Chan School of Public Health Boston, Boston, MA, 02115, USA.
Blood Cancer J ; 9(4): 39, 2019 03 26.
Article in En | MEDLINE | ID: mdl-30914633
ABSTRACT
Multiple myeloma (MM) and its precursor condition MGUS are characterized by chromosomal aberrations. Here, we comprehensively characterize the order of occurrence of these complex genomic events underlying MM development using 500 MGUS, and MM samples. We identify hyperdiploid MM (HMM) and non-HMM as genomically distinct entities with different evolution of the copy number alterations. In HMM, gains of 9,15 or 19 are the first and clonal events observed as clonal even at MGUS stage. These events are thus early and may underlie initial transformation of normal plasma cells to MGUS cells. However, CNAs may not be adequate for progression to MM except in 15% of the patients in whom the complex subclonal deletion events are observed in MM but not MGUS. In NHMM, besides the driver translocations, clonal deletion of 13 and 1q gain are early events also observed in MGUS. We combined this information to propose a timeline for copy number alteration.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Copy Number Variations / Multiple Myeloma Limits: Humans Language: En Journal: Blood Cancer J Year: 2019 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Copy Number Variations / Multiple Myeloma Limits: Humans Language: En Journal: Blood Cancer J Year: 2019 Document type: Article Affiliation country: United States